Episode 87 of TGen Talks features Dr. Haiyong Han, who dives into his latest work on one of the deadliest of cancers: pancreatic cancer.
He breaks down why this disease is so hard to catch early, how it can grow silently for years before symptoms appear, and why identifying true positives in general population is such a big challenge.
Dr. Han also shares promising progress toward a new non-invasive screening test that could one day enable earlier detection of pancreatic cancer. The goal? To turn this deadly disease into a more manageable condition, and give patients real hope for the future.
As we recognize Pancreatic Cancer Awareness Month in November, this episode emphasizes the urgent need for improved diagnostic methods, more effective treatments, and continued research to change the outcome for patients everywhere.
All content for TGen Talks is the property of TGen and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Episode 87 of TGen Talks features Dr. Haiyong Han, who dives into his latest work on one of the deadliest of cancers: pancreatic cancer.
He breaks down why this disease is so hard to catch early, how it can grow silently for years before symptoms appear, and why identifying true positives in general population is such a big challenge.
Dr. Han also shares promising progress toward a new non-invasive screening test that could one day enable earlier detection of pancreatic cancer. The goal? To turn this deadly disease into a more manageable condition, and give patients real hope for the future.
As we recognize Pancreatic Cancer Awareness Month in November, this episode emphasizes the urgent need for improved diagnostic methods, more effective treatments, and continued research to change the outcome for patients everywhere.
This month on TGen Talks, we get an insider’s perspective on how today’s biomedical research translates into tomorrow's treatments. We sit down with Stephanie Pond, Ph.D., Vice President of Emerging Opportunities at TGen.
We’ll Learn about the crucial role of TGen’s START and EDP programs – the Scientific Technology Assessment Research Team and Enterprise Directed Programs – in accelerating this process.
Dr. Pond explains how her team works to identify gaps in current research tools, partner with biotechnology companies to develop new technologies, and help commercialize TGen’s research discoveries. She highlights how advances in multiomics, single-cell sequencing, and spatial technologies are transforming biomedical research and enabling new diagnostic tests and treatments. Dr. Pond also discusses TGen's Enterprise Directed Programs, which focuses on taking research discoveries and developing scalable clinical tests and products.
Join us to hear Dr. Pond’s passion for technology and science and her dedication to bringing personalized medicine to life, faster.
TGen Talks
Episode 87 of TGen Talks features Dr. Haiyong Han, who dives into his latest work on one of the deadliest of cancers: pancreatic cancer.
He breaks down why this disease is so hard to catch early, how it can grow silently for years before symptoms appear, and why identifying true positives in general population is such a big challenge.
Dr. Han also shares promising progress toward a new non-invasive screening test that could one day enable earlier detection of pancreatic cancer. The goal? To turn this deadly disease into a more manageable condition, and give patients real hope for the future.
As we recognize Pancreatic Cancer Awareness Month in November, this episode emphasizes the urgent need for improved diagnostic methods, more effective treatments, and continued research to change the outcome for patients everywhere.
